We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$317M
AUM Growth
-$36.3M
(-10%)
Cap. Flow
-$25M
Cap. Flow
% of AUM
-7.9%
Top 10 Holdings %
Top 10 Hldgs %
56.14%
Holding
64
New
13
Increased
14
Reduced
15
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$8.9M |
| 2 |
CALY
Callaway Golf Company
CALY
|
+$8.67M |
| 3 |
Steris
STE
|
+$7.7M |
| 4 |
Henry Schein
HSIC
|
+$6.54M |
| 5 |
Tenet Healthcare
THC
|
+$5.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$12M |
| 2 |
Viatris
VTRS
|
+$11.7M |
| 3 |
CVS Health
CVS
|
+$8.34M |
| 4 |
Cigna
CI
|
+$8.3M |
| 5 |
Medtronic
MDT
|
+$6.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.12% |
| 2 | Consumer Staples | 4.15% |
| 3 | Consumer Discretionary | 3.93% |
| 4 | Technology | 1.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
CVS Health
CVS
$133B
| – | – |
-100,000
| Closed | -$8.34M |
|
52
Quest Diagnostics
DGX
$25.7B
| – | – |
-15,000
| Closed | -$1.98M |
|
53
CALL
SPDR Gold Trust
GLD
$131B
| – | – |
-5,000
| Closed | -$70K |
|
54
InnovAge Holding
INNV
$1.54B
| – | – |
-141,000
| Closed | -$3M |
|
55
Labcorp
LH
$25.4B
| – | – |
-1,164
| Closed | -$276K |
|
56
PUT
iShares S&P 100 ETF
OEF
$20.1B
| – | – |
-5,000
| Closed | -$1.59M |
|
|
57
UnitedHealth
UNH
$376B
| – | – |
-30,000
| Closed | -$12M |
|
|
58
Viatris
VTRS
$20.4B
| – | – |
-825,000
| Closed | -$11.7M |
|
59
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| – | – |
-1,500
| Closed | -$24K |
|
|
CMIIU
60
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| – | – |
-50,000
| Closed | -$673K |
|
|
MSACU
61
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
| – | – |
-296,636
| Closed | -$2.86M |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU
Tamarack Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, Tamarack Advisers held 64 positions worth $317M, down 10% from $353M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Tamarack Advisers withdrew a net $25M in Q3 2021, closing 19 positions and reducing 15 holdings. Its most notable exit was UnitedHealth, an estimated $12M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Tamarack Advisers opened a new position in Steris worth $7.35M.
- Tamarack Advisers's largest Q3 2021 buy was Steris: 36,000 shares worth $7.35M.
- Tamarack Advisers added most to Perrigo in Q3 2021, an estimated $8.9M increase.
- Tamarack Advisers's biggest Q3 2021 reduction was Medtronic, cutting an estimated $6.47M.
- Tamarack Advisers fully exited UnitedHealth in Q3 2021, selling an estimated $12M.
- Tamarack Advisers's ten largest holdings make up 56% of its $317M portfolio in Q3 2021.
- Tamarack Advisers opened 13 new positions and closed 19 in Q3 2021.
- Tamarack Advisers's portfolio value fell 10% quarter-over-quarter to $317M.
Based on Tamarack Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.